REGINA SAGLIBENE: Open Payments
NPI 1841906971 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 111 payments from 15 companies in 2025. Trend: 2023 $1,304 · 2024 $1,681 · 2025 $3,160
Food & beverage: $3,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $451 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $438 |
| Axsome Therapeutics, Inc. | 9 | $371 |
| Vanda Pharmaceuticals Inc. | 14 | $370 |
| Alkermes, Inc. | 8 | $297 |
| Janssen Pharmaceuticals, Inc | 6 | $260 |
| Otsuka America Pharmaceutical, Inc. | 8 | $207 |
| Supernus Pharmaceuticals, Inc. | 5 | $176 |
| E.R. Squibb & Sons, L.L.C. | 4 | $169 |
| Corium, LLC | 6 | $131 |
Products named: VRAYLAR, CAPLYTA, Auvelity, FANAPT, SPRAVATO, REXULTI, ARISTADA, Qelbree.
Industry payments across FL — which companies pay providers there.
